The another side of COVID‐19 in Alzheimer’s disease patients : Drug‐drug interactions
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
International Journal of Clinical Practice - 74(2020), 10 |
| Beteiligte Personen: |
Balli, Nisa [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
© 2020 John Wiley & Sons Ltd |
|---|
| Umfang: |
1 |
|---|
| doi: |
10.1111/ijcp.13596 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY007271395 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY007271395 | ||
| 003 | DE-627 | ||
| 005 | 20230307170020.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230216s2020 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/ijcp.13596 |2 doi | |
| 028 | 5 | 2 | |a IJCP_IJCP13596.xml |
| 035 | |a (DE-627)WLY007271395 | ||
| 035 | |a (WILEY)IJCP13596 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.60 |2 bkl | ||
| 100 | 1 | |a Balli, Nisa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a The another side of COVID‐19 in Alzheimer’s disease patients |b Drug‐drug interactions |
| 264 | 1 | |c 2020 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2020 John Wiley & Sons Ltd | ||
| 700 | 1 | |a Kara, Emre |4 aut | |
| 700 | 1 | |a Demirkan, Kutay |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International Journal of Clinical Practice |g 74(2020), 10 |w (DE-627)WLY007269595 |x 17421241 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2020 |g number:10 |g extent:1 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 936 | b | k | |a 44.60 |q ASE |
| 951 | |a AR | ||
| 952 | |d 74 |j 2020 |e 10 |g 1 | ||